Related content

Phase I Safety, Tolerability, and Pharmacokinetic Study of Recombinant Human Mannan-Binding Lectin

By Petersen Kenneth   Matthiesen Finn   Agger Teit   Kongerslev Leif   Thiel Steffen   Cornelissen Karen   Axelsen Mads  

Journal of Clinical Immunology, Vol. 26, Iss. 5, 2006-09 ,pp. : 465-475

Springer Publishing Company

Access to resources Recommend Favorite

Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals

By Moller-Kristensen M.   Jensenius J.C.   Jensen L.   Thielens N.   Rossi V.   Arlaud G.   Thiel S.  

Journal of Immunological Methods, Vol. 282, Iss. 1, 2003-11 ,pp. : 159-167

Elsevier

Access to resources Recommend Favorite

Evaluation of lectin pathway activity and mannan-binding lectin levels in the course of pregnancy complicated by diabetes type 1, based on the genetic background

By Pertyńska−Marczewska Magdalena   Cedzyński Maciej   Świerzko Anna   Szala Agnieszka   Sobczak Małgorzata   Cypryk Katarzyna   Wilczyński Jan  

Archivum Immunologiae et Therapiae Experimentalis, Vol. 57, Iss. 3, 2009-06 ,pp. : 221-228

Springer Publishing Company

Access to resources Recommend Favorite

Protective Molecules–C-Reactive Protein (CRP), Serum Amyloid P (SAP), Pentraxin3 (PTX3), Mannose-Binding Lectin (MBL), and Apolipoprotein A1 (Apo A1), and Their Autoantibodies: Prevalence and Clinical Significance in Autoimmunity

By Kravitz Martine   Pitashny Milena   Shoenfeld Yehuda  

Journal of Clinical Immunology, Vol. 25, Iss. 6, 2005-11 ,pp. : 582-591

Springer Publishing Company

Access to resources Recommend Favorite

Ligation of CD44 with low-molecular-weight hyaluronan and a monoclonal antibody leads to inhibition of drug-induced apoptosis in a human myeloid cell line

By Onoda Masahiro   Nakaseko Chiaki   Yokota Akira   Saito Yasushi  

Hematology, Vol. 14, Iss. 4, 2009-08 ,pp. : 213-219

Maney Publishing

Access to resources Recommend Favorite